All (n = 27) | No medical therapy (n = 5) | Rate control (n = 11) | Rhythm control (n = 11) | p value | |
---|---|---|---|---|---|
Age, years | 37.3 ± 7.9 | 29.2 ± 6.2 | 40.3 ± 7.2 | 38.0 ± 7.1 | 0.0147 |
Male, no. (%) | 27 (100%) | 5 (100%) | 11 (100%) | 11 (100%) | N/A |
BMI, kg/m2 | 27.3 ± 3.1 | 25.0 ± 3.8 | 28.8 ± 3.1 | 26.9 ± 1.8 | 0.1408 |
Caucasian, no. (%) | 23 (85%) | 5 (100%) | 7 (64%) | 11 (100%) | N/A |
African American, no. (%) | 1 (4%) | 0 (0%) | 1 (9%) | 0 (0%) | N/A |
Other race/unknown race, no. (%) | 3 (11%) | 0 (0%) | 3 (27%) | 0 (0%) | N/A |
Hypertension, no. (%) | 7 (26%) | 1 (20%) | 3 (27%) | 3 (27%) | 0.9431 |
Obstructive sleep apnea, no. (%) | 5 (19%) | 1 (20%) | 2 (18%) | 2 (18%) | 0.9956 |
History of heart failure, no. (%) | 1 (4%) | 0 (0%) | 1 (9%) | 0 (0%) | 0.3961 |
Glucose, mg/dL | 92.1 ± 11.5 | 93.8 ± 15.4 | 92.5 ± 8.5 | 91.1 ± 13.3 | 0.3401 |
Total cholesterol, mg/dL | 187.5 ± 27.0 | 194.2 ± 17.6 | 189.5 ± 34.9 | 182.5 ± 22.2 | 0.2335 |
LDL, mg/dL | 117.8 ± 22.7 | 108.3 ± 21.1 | 123.3 ± 27.8 | 115.8 ± 17.7 | 0.3409 |
HDL, mg/dL | 47.7 ± 9.9 | 57.1 ± 13.7 | 45.2 ± 5.8 | 46.0 ± 2.9 | 0.0612 |
Triglycerides, mg/dL | 115.6 ± 82.2 | 148.0 ± 156.7 | 110.9 ± 69.6 | 105.5 ± 47.3 | 0.8181 |
CHA2DS2-VASc score | 0.29 ± 0.47 | 0.20 ± 0.45 | 0.36 ± 0.50 | 0.27 ± 0.47 | 0.5732 |
HAS-BLED score | 0.74 ± 0.53 | 0.80 ± 0.45 | 0.64 ± 0.67 | 0.82 ± 0.40 | 0.3706 |
AF classification | |||||
Paroxysmal AF, no. (%) | 25 (93%) | 5 (100%) | 11 (100%) | 9 (82%) | N/A |
Persistent AF, no. (%) | 2 (7%) | 0 (0%) | 0 (0%) | 2 (18%) | N/A |